Already approved for smoking and treatment-resistant depression, brain stimulation is being tested for multiple addictions ...

LEONA Hargreaves was at work in 2024 when her world changed – she was having a suspected stroke. The 26-year-old dental nurse ...

Nocira LLC, a privately owned, Arizona-based medical device company (the "Company"), is pleased to announce that ...

Market Overview: The Vietnam Acute Migraine Drugs Market report provides an in-depth analysis of the industry, offering a comprehensive exploration of market dynamics and trends. Serving as a valuable ...

A migraine headache is usually a severe headache, often limited to one side of the head, and may be accompanied by nausea and ...

Atogepant, a recently approved drug for migraine, may start working as soon as day 1 of treatment, according to a recent study published in Neurology. | Neuroscience ...

What to do if leukemia becomes resistant to drug treatment? New therapy "starts with antibodies" to eradicate cancer cells ...

A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, ...

Difficulty balancing or an inability to do so can be caused by any number of factors. Head injuries, migraines, alcohol use, ear infections and medications can all affect your musculoskeletal system ...

A newly approved drug, atogepant, may start reducing migraines on the very first day of use, according to a study published ...

To help prevent migraines, the recommended starting dosage is 25 milligrams (mg) per day. To treat seizures, the typical starting dosage is 50 mg per day. Topamax is a brand-name drug approved by ...

A drug recently approved to prevent migraine may start working right away, according to a new study. The study looked at the drug atogepant, which is a calcitonin gene-related peptide (CGRP) receptor ...